Acasti Pharma Inc. (NASDAQ:ACST) is Worth a Shot if You're a Risk-Capital Investor

Retrieved on: 2021-06-22 11:26:15

Tags for this article:

Financial markets

Finance

Initial public offering

Acasti Pharma Inc.

Click the tags to see associated articles and topics

Acasti Pharma Inc. (NASDAQ:ACST) is Worth a Shot if You're a Risk-Capital Investor. View article details on hiswai:

Excerpt

There are 30 institutions holding the Acasti Pharma Inc. stock share, with Renaissance Technologies, LLC the top institutional holder. As of Dec 30, ...

Article found on: marketingsentinel.com

View Original Article